Pain Treatment in Multimorbid Patients, the Older Population and Other High-Risk Groups: The Clinical Challenge of Reducing Toxicity

Author： Wilder-Smith C.H.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.18, Iss.6, 1998-06, pp. : 457-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NMSC in Organ Transplant Recipients and Other High-Risk Groups

By Pennington Brent E.   Stasko Thomas  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 1, 2004-01 ,pp. : 31-41

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Hormesis and High-Risk Groups

By Calabrese E.J.   Baldwin L.A.  

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 3, 2002-06 ,pp. : 414-428

Academic Press

Access to resources Recommend Favorite

Paclitaxel-eluting stent rises to the challenge in high-risk patients

By  

Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 7, 2010-07 ,pp. : 17-20

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Hepatitis C-Related Interventions Targeting Substance Users and Other High-Risk Groups: A Systematic Review

By John-Baptiste Ava   >   Leung Victoria   >   Krahn Murray  

PharmacoEconomics, Vol. 30, Iss. 11, 2012-11 ,pp. : 1015-1034

Adis International

Access to resources Recommend Favorite